RxDoctor Payments DataLook up a doctor →

Lewis Kriteman, MD

Urology · Roswell, GANPI 1275638488

Payments from drug & device makers

$864,118in general payments, 2019–2025

Across 1,240 payments — averaging $696.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$740K
  • Boston Scientific$80K
  • Strauss Surgical USA LLC$14K
  • SRS Medical Systems, Inc.$4K
  • Axonics, Inc.$4K
  • Neotract Inc.$4K
  • plus $19K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Procept Biorobotics Corporation517$739,834
Boston Scientific185$79,570
Strauss Surgical USA LLC1$13,500
SRS Medical Systems, Inc.8$4,173
Axonics, Inc.65$4,132
Neotract Inc.28$4,104
Teleflex LLC30$3,119
Uromedica, Incorporated3$1,809
Koelis Inc.6$1,666
Laborie Medical Technologies Corp.13$1,226
Endo Pharmaceuticals Inc.41$1,062
Medtronic(2 entities)23$959
Palette Life Sciences, Inc.8$740
Dendreon Pharmaceuticals LLC23$668
Astellas Pharma US Inc27$612
Blue Earth Diagnostics23$545
Pfizer26$496
I/o Urology Corp.2$473
Sumitomo Pharma America, Inc.18$424
Bayer19$416
Merck11$378
AbbVie(2 entities)13$375
Myovant Sciences Inc.13$296
Antares Pharma, Inc.15$287
Endo USA, Inc.10$252
Tolmar, Inc.10$232
Johnson & Johnson(3 entities)7$219
AstraZeneca11$219
Ferring Pharmaceuticals Inc.12$205
Calyxo, Inc.3$192
Valencia Technologies Corporation3$187
KARL Storz Endoscopy-america1$182
Urovant Sciences Inc2$148
Tempus AI, Inc5$144
Healthtronics Stone Solutions, LLC1$125
Coloplast7$120
Progenics Pharmaceuticals, Inc.2$112
Photocure Inc1$98
Olympus America Inc.5$73
Tolmar Pharmaceuticals, Inc.4$69
Vertex2$60
Novartis2$53
Ambu Inc.2$53
Abbott2$52
Amgen2$52
Angiodynamics, Inc.2$49
Acerus Pharmaceuticals Corporation3$42
Kowa Pharmaceuticals America, Inc.3$37
Pharmaand GmbH1$30
Urogen Pharma, Inc.2$24
Convatec Inc.1$24
Davol Inc.1$22
Clarus Therapeutics Inc.1$18
Foundation Medicine, Inc.1$18
Sun Pharmaceutical Industries Inc.1$18
Immunitybio, Inc.1$17
Innovation Technologies Inc1$17
Myriad Genetic Laboratories, Inc.1$17
Travere Therapeutics, Inc.5$16
Baxter Healthcare1$16

How this compares

$864,118 in reported general payments places this provider in the 95th percentile of 369 urology providers in Georgia.

See all urology providers in Georgia

Medicare billing

Part B allowed, 2024
$472,784
Medicare patients
1,368
Services billed
9,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Roswell

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →